The Manufacturers Life Insurance Company acquired a new stake in HCA Healthcare, Inc. (NYSE:HCA – Free Report) in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 80,299 shares of the company’s stock, valued at approximately $31,308,000.
Several other institutional investors have also added to or reduced their stakes in HCA. Cetera Trust Company N.A purchased a new position in shares of HCA Healthcare in the second quarter worth about $1,179,000. Ally Financial Inc. purchased a new position in HCA Healthcare in the 2nd quarter worth approximately $2,339,000. Cibc World Market Inc. purchased a new stake in shares of HCA Healthcare during the second quarter valued at approximately $14,605,000. OMERS ADMINISTRATION Corp purchased a new position in shares of HCA Healthcare in the second quarter worth $4,832,000. Finally, Osmosis Investment Management UK Ltd purchased a new stake in HCA Healthcare during the 2nd quarter valued at $1,794,000. 62.73% of the stock is currently owned by hedge funds and other institutional investors.
HCA Healthcare Price Performance
Shares of HCA Healthcare stock opened at $419.19 on Friday. The firm’s 50-day moving average is $400.24 and its 200 day moving average is $441.63. The stock has a market cap of $90.75 billion, a price-to-earnings ratio of 14.03, a PEG ratio of 1.48 and a beta of 1.10. HCA Healthcare, Inc. has a 1 year low of $353.99 and a 1 year high of $556.52.
HCA Healthcare Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th will be issued a $0.78 dividend. This represents a $3.12 annualized dividend and a yield of 0.7%. The ex-dividend date is Wednesday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.45%.
Wall Street Analyst Weigh In
Several equities analysts have recently commented on the stock. The Goldman Sachs Group lowered their price objective on shares of HCA Healthcare from $558.00 to $485.00 and set a “buy” rating for the company in a research note on Tuesday, July 28th. Argus lowered their price target on HCA Healthcare from $560.00 to $500.00 and set a “buy” rating for the company in a research report on Monday, May 4th. Royal Bank Of Canada reiterated an “outperform” rating and issued a $435.00 price objective on shares of HCA Healthcare in a research report on Monday, July 27th. Wall Street Zen lowered HCA Healthcare from a “buy” rating to a “hold” rating in a research note on Saturday, May 2nd. Finally, Jefferies Financial Group set a $450.00 price objective on shares of HCA Healthcare in a report on Tuesday, July 14th. Fourteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $462.64.
Check Out Our Latest Stock Analysis on HCA Healthcare
HCA Healthcare Profile
HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Further Reading
- Five stocks we like better than HCA Healthcare
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
